Evaluating the efficacy and safety of a new peptide-based therapy for the treatment of amyotrophic lateral sclerosis (ALS)

Tag: Evaluating the efficacy and safety of a new peptide-based therapy for the treatment of amyotrophic lateral sclerosis (ALS)

control
Pharmacology
June 13, 2024

Evaluating the efficacy and safety of a new peptide-based therapy for the treatment of amyotrophic lateral sclerosis (ALS) – Complete Phd and Masters Thesis

[ad_1] Introduction Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects the motor neurons in the brain and spinal cord. This devastating disease leads to muscle weakness,…

Translate »